ARCHIVES

STI-571 Effects Are Lasting Against GI Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 25 No. 7 | July 26, 2002

Download PDF Visit The Full Archive

Related Articles

Capizzi Succeeds Spurr as Director Of Bowman Gray Cancer Center

September 10, 1982

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

Appropriations Committees Lean Toward Adding Some To NCI Budget; ACS To Ask Again For $1.5 Billion

April 20, 1984

Senate Confirms Kansas Gov. Sebelius For HHS Secretary

May 1, 2009

First Clinical Guidelines On Ductal Lavage Published

March 29, 2002

Reaction To PSA Guideline Muffled Compared to 2009 Mammography Guideline

October 14, 2011